Cephalosporin in crystalline form

Details for Australian Patent Application No. 2004224181 (hide)

Owner Basilea Pharmaceutica AG

Inventors Berghausen, Joerg

Agent Spruson & Ferguson

Pub. Number AU-B-2004224181

PCT Pub. Number WO2004/085444

Priority 03006815.9 27.03.03 EP

Filing date 15 March 2004

Wipo publication date 7 October 2004

Acceptance publication date 2 June 2011

International Classifications

C07D 501/56 (2006.01) Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins

A61K 31/04 (2006.01) - Nitro compounds

A61K 31/545 (2006.01) - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine

C07D 501/00 (2006.01) Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/085444 Priority application(s): WO2004/085444

2 June 2011 Application Accepted

  Published as AU-B-2004224181

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224191-Benzyl-pyridazinons as reverse transcriptase inhibitors

2004224179-Method of mounting tyres to civil engineering vehicles and associated tyre